Tumor response in primary kidney lesions and metastatic lesions in nivolumab plus ipilimumab therapy for advanced renal cell carcinoma without prior nephrectomy: Preliminary results of a multi-institutional study.
Hiroki IshiharaToshio TakagiKazuhiko YoshidaYasunobu HashimotoTsunenori KondoKazunari TanabePublished in: International journal of urology : official journal of the Japanese Urological Association (2021)